Skip to content

Clinical trials

Completed Phase 3 Metabolic Syndrome trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Metabolic Syndrome Phase: Phase 3 Status: Completed Clear all

44 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20022
20031
20042
20054
20062
20075
20086
20091
20102
20114
20121
20137
20143
20161
20191

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed44

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca3
Centro Universitario de Ciencias de la Salud, Mexico2
Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company2
GWT-TUD GmbH2
University Hospital, Basel, Switzerland2
University of Erlangen-Nürnberg Medical School2
University of Saskatchewan2
5 Santé1
Bambino Gesù Hospital and Research Institute1
Bjorn H. Ebdrup1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Metabolic Syndrome44
Obesity10
Hypertension6
Diabetes Mellitus, Type 25
Dyslipidemias5
Hyperglycemia4
Diabetes Mellitus3
Glucose Intolerance3
Hypercholesterolemia3
Insulin Resistance3

Trials

Showing 1 to 25 of 44. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.